Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2014

Open Access 01-12-2014 | Research article

Attitudes and barriers towards participation in an acupuncture trial among breast cancer patients: a survey study

Authors: Jun J Mao, Tiffany Tan, Susan Q Li, Salimah H Meghani, Karen Glanz, Deborah Bruner

Published in: BMC Complementary Medicine and Therapies | Issue 1/2014

Login to get access

Abstract

Background

As breast cancer patients increasingly use complementary and alternative medicine (CAM), clinical trials are needed to guide appropriate clinical use. We sought to identify socio-demographic, clinical and psychological factors related to willingness to participate (WTP) and to determine barriers to participation in an acupuncture clinical trial among breast cancer patients.

Methods

We conducted a cross-sectional survey study among post-menopausal women with stage I-III breast cancer on aromatase inhibitors at an urban academic cancer center.

Results

Of the 300 participants (92% response rate), 148 (49.8%) reported WTP in an acupuncture clinical trial. Higher education (p = 0.001), increased acupuncture expectancy (p < 0.001), and previous radiation therapy (p = 0.004) were significantly associated with WTP. Travel difficulty (p = 0.002), concern with experimentation (p = 0.013), and lack of interest in acupuncture (p < 0.001) were significant barriers to WTP. Barriers differed significantly by socio-demographic factors with white people more likely to endorse travel difficulty (p = 0.018) and non-white people more likely to report concern with experimentation (p = 0.024). Older patients and those with lower education were more likely to report concern with experimentation and lack of interest in acupuncture (p < 0.05).

Conclusions

Although nearly half of the respondents reported WTP, significant barriers to participation exist and differ among subgroups. Research addressing these barriers is needed to ensure effective accrual and improve the representation of individuals from diverse backgrounds.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 2012, 62 (1): 10-29. 10.3322/caac.20138.CrossRefPubMed Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 2012, 62 (1): 10-29. 10.3322/caac.20138.CrossRefPubMed
2.
go back to reference Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J: Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surviv. 2011, 5 (1): 8-17. 10.1007/s11764-010-0153-7.CrossRefPubMed Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J: Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surviv. 2011, 5 (1): 8-17. 10.1007/s11764-010-0153-7.CrossRefPubMed
3.
go back to reference Phillips KM, McGinty HL, Gonzalez BD, Jim HS, Small BJ, Minton S, Andrykowski MA, Jacobsen PB: Factors associated with breast cancer worry 3 years after completion of adjuvant treatment. Psychooncology. 2013, 22 (4): 936-939. 10.1002/pon.3066.CrossRefPubMed Phillips KM, McGinty HL, Gonzalez BD, Jim HS, Small BJ, Minton S, Andrykowski MA, Jacobsen PB: Factors associated with breast cancer worry 3 years after completion of adjuvant treatment. Psychooncology. 2013, 22 (4): 936-939. 10.1002/pon.3066.CrossRefPubMed
4.
go back to reference Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M: It’s not over when it’s over: long-term symptoms in cancer survivors–a systematic review. Int J Psychiatry Med. 2010, 40 (2): 163-181. 10.2190/PM.40.2.c.CrossRefPubMed Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M: It’s not over when it’s over: long-term symptoms in cancer survivors–a systematic review. Int J Psychiatry Med. 2010, 40 (2): 163-181. 10.2190/PM.40.2.c.CrossRefPubMed
5.
go back to reference Baker F, Denniston M, Smith T, West MM: Adult cancer survivors: how are they faring?. Cancer. 2005, 104 (11 Suppl): 2565-2576.CrossRefPubMed Baker F, Denniston M, Smith T, West MM: Adult cancer survivors: how are they faring?. Cancer. 2005, 104 (11 Suppl): 2565-2576.CrossRefPubMed
6.
go back to reference Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT: Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med. 2007, 20 (5): 434-443. 10.3122/jabfm.2007.05.060225.CrossRefPubMed Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT: Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med. 2007, 20 (5): 434-443. 10.3122/jabfm.2007.05.060225.CrossRefPubMed
7.
go back to reference Jacobson JS, Workman SB, Kronenberg F: Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature. J Clin Oncol. 2000, 18 (3): 668-683.PubMed Jacobson JS, Workman SB, Kronenberg F: Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature. J Clin Oncol. 2000, 18 (3): 668-683.PubMed
8.
go back to reference Jones LW, Demark-Wahnefried W: Diet, exercise, and complementary therapies after primary treatment for cancer. Lancet Oncol. 2006, 7 (12): 1017-1026. 10.1016/S1470-2045(06)70976-7.CrossRefPubMed Jones LW, Demark-Wahnefried W: Diet, exercise, and complementary therapies after primary treatment for cancer. Lancet Oncol. 2006, 7 (12): 1017-1026. 10.1016/S1470-2045(06)70976-7.CrossRefPubMed
9.
go back to reference Nahleh Z, Tabbara IA: Complementary and alternative medicine in breast cancer patients. Palliat Support Care. 2003, 1 (3): 267-273.CrossRefPubMed Nahleh Z, Tabbara IA: Complementary and alternative medicine in breast cancer patients. Palliat Support Care. 2003, 1 (3): 267-273.CrossRefPubMed
10.
go back to reference Levine AS, Balk JL: Yoga and quality-of-life improvement in patients with breast cancer: a literature review. Int J Yoga Ther. 2012, 22: 95-99. Levine AS, Balk JL: Yoga and quality-of-life improvement in patients with breast cancer: a literature review. Int J Yoga Ther. 2012, 22: 95-99.
11.
go back to reference Morris KT, Johnson N, Homer L, Walts D: A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg. 2000, 179 (5): 407-411. 10.1016/S0002-9610(00)00358-5.CrossRefPubMed Morris KT, Johnson N, Homer L, Walts D: A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg. 2000, 179 (5): 407-411. 10.1016/S0002-9610(00)00358-5.CrossRefPubMed
12.
go back to reference Boon HS, Olatunde F, Zick SM: Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health. 2007, 7: 4-10.1186/1472-6874-7-4.CrossRefPubMedPubMedCentral Boon HS, Olatunde F, Zick SM: Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health. 2007, 7: 4-10.1186/1472-6874-7-4.CrossRefPubMedPubMedCentral
13.
go back to reference Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D: Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst. 2000, 92 (1): 42-47. 10.1093/jnci/92.1.42.CrossRefPubMed Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D: Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst. 2000, 92 (1): 42-47. 10.1093/jnci/92.1.42.CrossRefPubMed
14.
go back to reference Wyatt G, Sikorskii A, Wills CE, Su H: Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer. Nurs Res. 2010, 59 (1): 58-66. 10.1097/NNR.0b013e3181c3bd26.CrossRefPubMed Wyatt G, Sikorskii A, Wills CE, Su H: Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer. Nurs Res. 2010, 59 (1): 58-66. 10.1097/NNR.0b013e3181c3bd26.CrossRefPubMed
15.
go back to reference Matthews AK, Sellergren SA, Huo D, List M, Fleming G: Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med. 2007, 13 (5): 555-562. 10.1089/acm.2007.03-9040.CrossRefPubMed Matthews AK, Sellergren SA, Huo D, List M, Fleming G: Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med. 2007, 13 (5): 555-562. 10.1089/acm.2007.03-9040.CrossRefPubMed
16.
go back to reference Cheng SK, Dietrich MS, Dilts DM: A sense of urgency: Evaluating the link between clinical trial development time and the accrual performance of cancer therapy evaluation program (NCI-CTEP) sponsored studies. Clin Cancer Res. 2010, 16 (22): 5557-5563. 10.1158/1078-0432.CCR-10-0133.CrossRefPubMedPubMedCentral Cheng SK, Dietrich MS, Dilts DM: A sense of urgency: Evaluating the link between clinical trial development time and the accrual performance of cancer therapy evaluation program (NCI-CTEP) sponsored studies. Clin Cancer Res. 2010, 16 (22): 5557-5563. 10.1158/1078-0432.CCR-10-0133.CrossRefPubMedPubMedCentral
17.
go back to reference Cheng SK, Dietrich MS, Dilts DM: Predicting accrual achievement: monitoring accrual milestones of NCI-CTEP-sponsored clinical trials. Clin Cancer Res. 2011, 17 (7): 1947-1955. 10.1158/1078-0432.CCR-10-1730.CrossRefPubMedPubMedCentral Cheng SK, Dietrich MS, Dilts DM: Predicting accrual achievement: monitoring accrual milestones of NCI-CTEP-sponsored clinical trials. Clin Cancer Res. 2011, 17 (7): 1947-1955. 10.1158/1078-0432.CCR-10-1730.CrossRefPubMedPubMedCentral
18.
go back to reference Lamberti MJ: A Sourcebook of Charts and Statistics. State of the Clinical Trials Industry. 2009, Boston: CenterWatch, 5 Lamberti MJ: A Sourcebook of Charts and Statistics. State of the Clinical Trials Industry. 2009, Boston: CenterWatch, 5
19.
go back to reference Murthy VH, Krumholz HM, Gross CP: Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004, 291 (22): 2720-2726. 10.1001/jama.291.22.2720.CrossRefPubMed Murthy VH, Krumholz HM, Gross CP: Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004, 291 (22): 2720-2726. 10.1001/jama.291.22.2720.CrossRefPubMed
20.
go back to reference Lara PN, Paterniti DA, Chiechi C, Turrell C, Morain C, Horan N, Montell L, Gonzalez J, Davis S, Umutyan A: Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol. 2005, 23 (36): 9282-9289. 10.1200/JCO.2005.02.6245.CrossRefPubMed Lara PN, Paterniti DA, Chiechi C, Turrell C, Morain C, Horan N, Montell L, Gonzalez J, Davis S, Umutyan A: Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol. 2005, 23 (36): 9282-9289. 10.1200/JCO.2005.02.6245.CrossRefPubMed
21.
go back to reference Mills EJ, Seely D, Rachlis B, Griffith L, Wu P, Wilson K, Ellis P, Wright JR: Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol. 2006, 7 (2): 141-148. 10.1016/S1470-2045(06)70576-9.CrossRefPubMed Mills EJ, Seely D, Rachlis B, Griffith L, Wu P, Wilson K, Ellis P, Wright JR: Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol. 2006, 7 (2): 141-148. 10.1016/S1470-2045(06)70576-9.CrossRefPubMed
22.
go back to reference Gross CP, Filardo G, Mayne ST, Krumholz HM: The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer. 2005, 103 (3): 483-491. 10.1002/cncr.20792.CrossRefPubMed Gross CP, Filardo G, Mayne ST, Krumholz HM: The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer. 2005, 103 (3): 483-491. 10.1002/cncr.20792.CrossRefPubMed
23.
go back to reference Ellis PM, Butow PN, Tattersall MH, Dunn SM, Houssami N: Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol. 2001, 19 (15): 3554-3561.PubMed Ellis PM, Butow PN, Tattersall MH, Dunn SM, Houssami N: Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol. 2001, 19 (15): 3554-3561.PubMed
24.
go back to reference Trauth JM, Musa D, Siminoff L, Jewell IK, Ricci E: Public attitudes regarding willingness to participate in medical research studies. J Health Soc Policy. 2000, 12 (2): 23-43. 10.1300/J045v12n02_02.CrossRefPubMed Trauth JM, Musa D, Siminoff L, Jewell IK, Ricci E: Public attitudes regarding willingness to participate in medical research studies. J Health Soc Policy. 2000, 12 (2): 23-43. 10.1300/J045v12n02_02.CrossRefPubMed
25.
go back to reference Richardson MA, Post-White J, Singletary SE, Justice B: Recruitment for complementary/alternative medicine trials: who participates after breast cancer. Ann Behav Med. 1998, 20 (3): 190-198. 10.1007/BF02884960.CrossRefPubMed Richardson MA, Post-White J, Singletary SE, Justice B: Recruitment for complementary/alternative medicine trials: who participates after breast cancer. Ann Behav Med. 1998, 20 (3): 190-198. 10.1007/BF02884960.CrossRefPubMed
26.
go back to reference Comis RL, Miller JD, Aldige CR, Krebs L, Stoval E: Public attitudes toward participation in cancer clinical trials. J Clin Oncol. 2003, 21 (5): 830-835. 10.1200/JCO.2003.02.105.CrossRefPubMed Comis RL, Miller JD, Aldige CR, Krebs L, Stoval E: Public attitudes toward participation in cancer clinical trials. J Clin Oncol. 2003, 21 (5): 830-835. 10.1200/JCO.2003.02.105.CrossRefPubMed
27.
go back to reference Baggstrom MQ, Waqar SN, Sezhiyan AK, Gilstrap E, Gao F, Morgensztern D, Govindan R: Barriers to enrollment in non-small cell lung cancer therapeutic clinical trials. J Thorac Oncol. 2011, 6 (1): 98-102. 10.1097/JTO.0b013e3181fb50d8.CrossRefPubMed Baggstrom MQ, Waqar SN, Sezhiyan AK, Gilstrap E, Gao F, Morgensztern D, Govindan R: Barriers to enrollment in non-small cell lung cancer therapeutic clinical trials. J Thorac Oncol. 2011, 6 (1): 98-102. 10.1097/JTO.0b013e3181fb50d8.CrossRefPubMed
28.
go back to reference Agrawal M, Grady C, Fairclough DL, Meropol NJ, Maynard K, Emanuel EJ: Patients’ Decision-making process regarding participation in phase I oncology research. J Clin Oncol. 2006, 24 (27): 4479-4484. 10.1200/JCO.2006.06.0269.CrossRefPubMed Agrawal M, Grady C, Fairclough DL, Meropol NJ, Maynard K, Emanuel EJ: Patients’ Decision-making process regarding participation in phase I oncology research. J Clin Oncol. 2006, 24 (27): 4479-4484. 10.1200/JCO.2006.06.0269.CrossRefPubMed
29.
go back to reference Brauer JA, El Sehamy A, Metz JM, Mao JJ: Complementary and alternative medicine and supportive care at leading cancer centers: a systematic analysis of websites. J Altern Complement Med. 2010, 16 (2): 183-186. 10.1089/acm.2009.0354.CrossRefPubMedPubMedCentral Brauer JA, El Sehamy A, Metz JM, Mao JJ: Complementary and alternative medicine and supportive care at leading cancer centers: a systematic analysis of websites. J Altern Complement Med. 2010, 16 (2): 183-186. 10.1089/acm.2009.0354.CrossRefPubMedPubMedCentral
30.
go back to reference Mao JJ, Stricker C, Bruner D, Xie S, Bowman MA, Farrar JT, Greene BT, DeMichele A: Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer. 2009, 115 (16): 3631-3639. 10.1002/cncr.24419.CrossRefPubMedPubMedCentral Mao JJ, Stricker C, Bruner D, Xie S, Bowman MA, Farrar JT, Greene BT, DeMichele A: Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer. 2009, 115 (16): 3631-3639. 10.1002/cncr.24419.CrossRefPubMedPubMedCentral
31.
go back to reference Schneider J, Vuckovic N, DeBar L: Willingness to participate in complementary and alternative medicine clinical trials among patients with craniofacial disorders. J Altern Complement Med. 2003, 9 (3): 389-401. 10.1089/107555303765551615.CrossRefPubMed Schneider J, Vuckovic N, DeBar L: Willingness to participate in complementary and alternative medicine clinical trials among patients with craniofacial disorders. J Altern Complement Med. 2003, 9 (3): 389-401. 10.1089/107555303765551615.CrossRefPubMed
32.
go back to reference Upchurch DM, Chyu L: Use of complementary and alternative medicine among American women. Womens Health Issues. 2005, 15 (1): 5-13. 10.1016/j.whi.2004.08.010.CrossRefPubMed Upchurch DM, Chyu L: Use of complementary and alternative medicine among American women. Womens Health Issues. 2005, 15 (1): 5-13. 10.1016/j.whi.2004.08.010.CrossRefPubMed
33.
go back to reference Wanchai A, Armer JM, Stewart BR: Complementary and alternative medicine use among women with breast cancer: a systematic review. Clin J Oncol Nurs. 2010, 14 (4): E45-E55. 10.1188/10.CJON.E45-E55.CrossRefPubMed Wanchai A, Armer JM, Stewart BR: Complementary and alternative medicine use among women with breast cancer: a systematic review. Clin J Oncol Nurs. 2010, 14 (4): E45-E55. 10.1188/10.CJON.E45-E55.CrossRefPubMed
34.
go back to reference Ellis PM: Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Ann Oncol. 2000, 11 (8): 939-945. 10.1023/A:1008342222205.CrossRefPubMed Ellis PM: Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Ann Oncol. 2000, 11 (8): 939-945. 10.1023/A:1008342222205.CrossRefPubMed
35.
go back to reference Mao JJ, Armstrong K, Farrar JT, Bowman MA: Acupuncture expectancy scale: development and preliminary validation in China. Explore (NY). 2007, 3 (4): 372-377. 10.1016/j.explore.2006.12.003.CrossRef Mao JJ, Armstrong K, Farrar JT, Bowman MA: Acupuncture expectancy scale: development and preliminary validation in China. Explore (NY). 2007, 3 (4): 372-377. 10.1016/j.explore.2006.12.003.CrossRef
36.
go back to reference Mao JJ, Xie SX, Bowman MA: Uncovering the expectancy effect: the validation of the acupuncture expectancy scale. Altern Ther Health Med. 2010, 16 (6): 22-27.PubMedPubMedCentral Mao JJ, Xie SX, Bowman MA: Uncovering the expectancy effect: the validation of the acupuncture expectancy scale. Altern Ther Health Med. 2010, 16 (6): 22-27.PubMedPubMedCentral
37.
go back to reference Ellis PM, Dowsett SM, Butow PN, Tattersall MH: Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinic. Health Expect. 1999, 2 (1): 33-43. 10.1046/j.1369-6513.1999.00028.x.CrossRefPubMed Ellis PM, Dowsett SM, Butow PN, Tattersall MH: Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinic. Health Expect. 1999, 2 (1): 33-43. 10.1046/j.1369-6513.1999.00028.x.CrossRefPubMed
38.
go back to reference Colagiuri B, Smith CA: A systematic review of the effect of expectancy on treatment responses to acupuncture. Evid Based Complement Alternat Med. 2012, 2012: 857804-CrossRefPubMed Colagiuri B, Smith CA: A systematic review of the effect of expectancy on treatment responses to acupuncture. Evid Based Complement Alternat Med. 2012, 2012: 857804-CrossRefPubMed
39.
go back to reference Linde K, Witt CM, Streng A, Weidenhammer W, Wagenpfeil S, Brinkhaus B, Willich SN, Melchart D: The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain. 2007, 128 (3): 264-271. 10.1016/j.pain.2006.12.006.CrossRefPubMed Linde K, Witt CM, Streng A, Weidenhammer W, Wagenpfeil S, Brinkhaus B, Willich SN, Melchart D: The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain. 2007, 128 (3): 264-271. 10.1016/j.pain.2006.12.006.CrossRefPubMed
40.
go back to reference Pariente J, White P, Frackowiak RS, Lewith G: Expectancy and belief modulate the neuronal substrates of pain treated by acupuncture. Neuroimage. 2005, 25 (4): 1161-1167. 10.1016/j.neuroimage.2005.01.016.CrossRefPubMed Pariente J, White P, Frackowiak RS, Lewith G: Expectancy and belief modulate the neuronal substrates of pain treated by acupuncture. Neuroimage. 2005, 25 (4): 1161-1167. 10.1016/j.neuroimage.2005.01.016.CrossRefPubMed
41.
go back to reference Kong J, Kaptchuk TJ, Polich G, Kirsch I, Vangel M, Zyloney C, Rosen B, Gollub RL: An fMRI study on the interaction and dissociation between expectation of pain relief and acupuncture treatment. Neuroimage. 2009, 47 (3): 1066-1076. 10.1016/j.neuroimage.2009.05.087.CrossRefPubMedPubMedCentral Kong J, Kaptchuk TJ, Polich G, Kirsch I, Vangel M, Zyloney C, Rosen B, Gollub RL: An fMRI study on the interaction and dissociation between expectation of pain relief and acupuncture treatment. Neuroimage. 2009, 47 (3): 1066-1076. 10.1016/j.neuroimage.2009.05.087.CrossRefPubMedPubMedCentral
42.
go back to reference Corbie-Smith G, Thomas SB, St George DM: Distrust, race, and research. Arch Intern Med. 2002, 162 (21): 2458-2463. 10.1001/archinte.162.21.2458.CrossRefPubMed Corbie-Smith G, Thomas SB, St George DM: Distrust, race, and research. Arch Intern Med. 2002, 162 (21): 2458-2463. 10.1001/archinte.162.21.2458.CrossRefPubMed
43.
go back to reference Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S: Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med. 1999, 14 (9): 537-546. 10.1046/j.1525-1497.1999.07048.x.CrossRefPubMedPubMedCentral Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S: Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med. 1999, 14 (9): 537-546. 10.1046/j.1525-1497.1999.07048.x.CrossRefPubMedPubMedCentral
Metadata
Title
Attitudes and barriers towards participation in an acupuncture trial among breast cancer patients: a survey study
Authors
Jun J Mao
Tiffany Tan
Susan Q Li
Salimah H Meghani
Karen Glanz
Deborah Bruner
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2014
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-14-7

Other articles of this Issue 1/2014

BMC Complementary Medicine and Therapies 1/2014 Go to the issue